EARLY HEART AGING IN OBSTRUCTIVE SLEEP APNEA SYNDROME
DOI: 10.22138/2500-0918-2018-15-3-337-345
T.O. Brodovskaya, O.O. Grishenko, K.P. Usenko, I.F. Grishina, T.F. Peretolchina
Ural State Medical University, Yekaterinburg, Russian Federation
Abstract. With aging, certain structural and functional heart changes are on, which are currently considered as the concept of «heart aging.» Aging can be influenced with various factors. Objective. To analyze obstructive sleep apnea syndrome (OSA) impact at early heart aging. Material and methods. A total of 72 male patients were examined, the average age being 39,3±7,1 years. All patients underwent cardiorespiratory monitoring and echocardiography. Based on the results of the survey, 2 groups were formed, the main group consisted of 41 patients with OSA, the control group was represented by 31 healthy people. Results. In OSA patients were structional heart changes, systolic and diastolic functions features that indicate an overload with both volume and resistance, left ventricle hypertrophy, eccentric remodeling pattern. Conclusion. OSA can be considered as a factor of early heart aging.
Keywords: оbstructive sleep apnea syndrome, heart aging, remodeling
There is no conflict of interest.
Contact information of the author responsible for correspondence:
Tatyana O. Brodovskaya
tbrod80@gmail.com
Received 25.04.2018
For citation:
Brodovskaya T.O., Grishenko O.O., Usenko K.P., Grishina L.F., Peretolchina T.F. Early heart aging in obstructive sleep apnea syndrome. Vestn. Ural. Med. Akad. Nauki. = Journal of Ural Medical Academic Science. 2018, Vol. 15, no. 3, pp. 337–345. DOI: 10,22138/2500-0918-2018-15-3-337-345 (In Russ)
REFERENCES
1. Bartzokis G., Lu P.H., Tingus K et al. Lifespan trajectory of myelin integrity and maximum motor speed. Neurobiology of Aging. 2010. Vol. 8. P. 1554–1562. doi: 10,1016/j.neurobiolaging,2008,08,015.
2. Chiao Y.A., Rabinovich P.S. The aging heart. Cold Spring Harbor Perspectives in Medicine. 2015. Vol. 5. P.a025148. doi: 10,1101/cshperspect.a025148.
3. Steenman M., Lande G. Cardiac aging and heart disease in humans. Biophysical Reviews. 2017.Vol. 9. P,131–137. Doi: 10,1007/s12551-017-0255-9
4. Strait J.B., Lakatta E.G. Aging-associated cardiovascular changes and their relationship to heart failure. Heart Failure Clinics. 2012. Vol. 1.P. 143–164. doi: 10,1016/j.hfc,2011,08,011.
5. Akasheva D.U, Strazhesko I.D., DudinskayaE.N. et al. Heart and Age (Part I): Theories of Aging, Morphological Changes. Cardiovascular Therapy and Prevention. 2013. No. 1. P. 88-94. (InRuss.)
6. Akasheva D.U, Plokhova E.V., Strazhesko I.D. et al. Heart and age (part II): clinical manifestations of aging. Cardiovascular therapy and prevention. 2013. № 4. P,86-90. (InRuss.)
7. Akasheva D.U, Plokhova E.V., Strazhesko I.D. et al. Heart and age (part III): methods of influence on aging processes. Cardiovascular therapy and prevention. 2013. N. 5.P,91-96. (InRuss.)
8. Ramar K., Dort L.C., Katz S.G., et al. Clinical Practice Guideline for the Treatment of Obstructive Sleep Apnea and Snoring with Oral Appliance Therapy: An Update for 2015. Journal of Clinical Sleep Medicine. 2015.Vol,7.P,773–827. doi: 10,5664/jcsm,4858.
9. Lakatta E.G., Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part II: the aging heart in health: links to heart disease. Circulation. 2003. Vol. 107. P. 346–354. doi:10,1161/01.
10. Foster G.E., Poulin M.J., Hanly P.J. Intermittent hypoxia and vascular function: implications for obstructive sleep apnoea. Experimеntal Physiology,1992.Vol1.P. 51–65.
11. Ziello J.E., Jovi I.S., Huan Y. Hypoxia-InducibleFactor(HIF)-1RegulatoryPathway and its Potential for Therapeutic Intervention in Malignancy and Ischemia. Yale journal of biology and medicine,2007.Vol,80.P,51-60.
12. Nilsson P.M. Early vascular aging: consequences and prevention. Vascular Health and Risk Management. 2008. Vol,3. P,547-552.
13. Steenman M., Lande G. Cardiac aging and heart disease in humans. Biophysical Review. 2017. Vol. 9. P. 131–137. doi: 10,1007/s12551-017-0255-9
14. Nikitin N.P., Loh P.H., de Silva R. et al. Left ventricular morphology, global and longitudinal function in normal older individuals: a cardiac magnetic resonance study. International Journal of Cardiology. 2006. Vol. 1. P. 76–83.
15. Chami H.A., Devereux R.B., Gottdiener J.S et al. Left ventricular morphology and systolic function in sleep-disordered breathing the sleep heart health study. Circulation. 2008. Vol,20. P. 2599-2607. doi: 10,1161/CIRCULATIONAHA,107,717892.
16. Noda A., Okada, T., Yasuma F. Cardiac hypertrophy in obstructive sleep apnea syndrome. Chest. 1995. Vol. 6. P. 1538-1544.
17. Calvin A.D., Albuquerque F.N., Lopez-Jimenez F. et al. Obstructive Sleep Apnea, Inflammation and the Metabolic Syndrome. Metabolic syndrome and related disorders. 2009. Vol,7. P. 271–278. doi: 10,1089/met,2008,0093
18. Baguet J-P., Barone-Rochette G., Lévy P. et al. Left ventricular diastolic dysfunction is linked to severity of obstructive sleep apnoea. European Respiratory Journal. 2010.Vol,6. P. 1323-1329. doi: 10,1183/09031936,00165709.
19. Wachter R., Lüthje L., Klemmstein D. et al. Impact of obstructive sleep apnoea on diastolic function. European Respiratory Journal. 2013.Vol. 2. P. 376-383. doi: 10,1183/09031936,00218211.
20. Bodez D., Langa S., Meuleman C. et al. Left ventricular diastolic dysfunction in obstructive sleep apnoea syndrome by an echocardiographic standardized approach: An observational study. Archive of Cardiovascular Disease. 2015. Vol. 10.P,480-490. doi: 10,1016/j.acvd,2015,03,006.
21. Miwa Y., Sagaguri T. Hypoxia-Induced Cardiac Remodeling in Sleep Apnea Syndrome: Involvement of the Renin Angiotensin — Aldosterone System. Hypertension Research. 2007. Vol. 30.P,1147–1149. doi: 10,1291/hypres,30,1147.
22. Zaichik A.Sh., Gurilov L.P. Fundamentals of general pathology. Part 2. / A.Sh. Zaichik, L.P. Gurilov. — Fundamentals of pathochemistry. — SPb .:ELBI, 2000. – 687p. (InRuss.)
23. Bizenkova M.N., Romantsov M.G, Chesnokova N.P. Metabolic effects of antioxidants in acute hypoxic hypoxia. Fundamental research. 2006. № 1. P. 17-21. (InRuss.)
24. Koga S., Ikeda S., Urata J., Kohno S. Effect of Nasal Continuous Positive Airway Pressure in Men on Global Left Ventricular Myocardial Performance in Patients With Obstructive Sleep Apnea Syndrome. American Journal of Cardiology. 2008. Vol. 12. P. 1796-1800. doi: 10,1016/j.amjcard,2008,02,083.
Authors
Tatyana O. Brodovskaya
Ural State Medical University
Cand. Sci. (Med.), Assistant of the Department
Russian Federation, 620039 Yekaterinburg, Suvorovsky pereulok, 5
tbrod80@gmail.com
Olga O. Grischenko
Federal State Institution «Central Military Clinical Hospital named P.V. Mandryka
MD
Russian Federation, 121002, Moscow, Serebryanyj pereulok, 4
Olga.nov@mail.ru
Kseniya P. Usenko
State Sverdlovsk Region Hospital №2
MD
Russian Federation, 620000, Yekaterinburg, ul. Naberezhnaya rabochej molodezhi, d. 3
kpus@bk.ru
Irina F. Grishina
Ural State Medical University
Dr. Sci. (Med.), Professor, Head of the Department of Polyclinic Therapy, Ultrasound and Functional Diagnostics
Russian Federation, 620039 Yekaterinburg, Suvorovsky pereulok, 5
Grishina@edc.nexcom.ru
Tatyana F. Peretolchina
Ural State Medical University
Dr. Sci. (Med.), Professor, Head of the Department of Esetics Medicine
Russian Federation, 620000 Yekaterinburg, ul. Sheinkmana 21
2019806@bk.ru